Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug-Reference-Cited by-同舟云学术

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

Published:2018-03-09 Issue:5 Volume:84 Page:997-1005
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Zhao Wei¹²³^ORCID,Leroux Stéphanie³⁴,Biran Valérie⁵,Jacqz-Aigrain Evelyne³⁶⁷^ORCID

Affiliation:

1. Department of Clinical Pharmacy, School of Pharmaceutical Sciences; Shandong University; Jinan China

2. Department of Pharmacy, Shandong Provincial Qianfoshan Hospital; Shandong University; Jinan China

3. Department of Paediatric Pharmacology and Pharmacogenetics; Robert Debré University Hospital, Assistance Publique - Hôpitaux de Paris; Paris France

4. Department of Neonatology; Rennes University Hospital; Rennes France

5. Department of Neonatology; Robert Debré University Hospital, Assistance Publiqqiue - Hôpitaux de Paris; Paris France

6. Clinical Investigation Center CIC1426; INSERM; Paris France

7. EA7323, University Paris Diderot - Sorbonne Paris Cité; Paris France

Funder

Ministère des Affaires Sociales et de la Santé

EU-funded FP7 project

Young Taishan Scholars Program

Young Scholars Program of Shandong University

National Science and Technology Major Projects

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.13526/fullpdf

Reference33 articles.

1. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Drug metabolism for the paediatrician;Hines;Pharmacol Ther,2008

2. Drug metabolism for the paediatrician;Wildt;Arch Dis Child,2014

3. Developmental pharmacology - drug disposition, action, and therapy in infants and children;Kearns;N Engl J Med,2003

4. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily;Goldstein;Br J Clin Pharmacol,2001

5. Impact of the CYP2C19*17 allele on the pharmacokinetics of omeprazole and pantoprazole inchildren: evidence for a differential effect;Kearns;Drug Metab Dispos,2010

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative prediction of CYP3A induction-mediated drug-drug interactions in clinical practice;Drug Metabolism and Pharmacokinetics;2024-08

2. Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis;International Journal of Molecular Sciences;2024-03-26

3. Pharmacokinetic, Pharmacodynamic, Preclinical and Clinical Models for Evaluation of Nanoparticles;Pharmacokinetics and Pharmacodynamics of Novel Drug Delivery Systems: From Basic Concepts to Applications;2024

4. Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes;Pharmacogenomics;2023-10

5. Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice;Molecular Genetics and Metabolism;2022-09